Buyer Name: NHS England
Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
Contact Email: katie.noonan@nhs.net
Buyer Name: NHS England
Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
Contact Email: katie.noonan@nhs.net
Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework. Additional Unsuccessful supplier not listed due to technical error: Torrent Pharma (UK) Ltd
Lot 1 Status: complete
Document Description: Not published
Contract Title: NHS National Framework for Transition products (Nilotinib and Ticagrelor)
{
"awards": [
{
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-14646636",
"name": "Zydus Pharmaceuticals UK Ltd"
},
{
"id": "GB-COH-00079585",
"name": "Accord-UK Ltd"
},
{
"id": "GB-COH-03674842",
"name": "AstraZeneca"
},
{
"id": "GB-COH-01729064",
"name": "Dr.Reddy\u0027s Laboratories (UK) Limited"
},
{
"id": "GB-COH-10185013",
"name": "MSN Laboratories Europe Limited"
},
{
"id": "GB-COH-00119006",
"name": "Novartis Pharmaceuticals UK Ltd"
},
{
"id": "GB-COH-02158996",
"name": "Zentiva Pharma UK Ltd"
}
]
}
],
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"contracts": [
{
"aboveThreshold": true,
"awardID": "1",
"dateSigned": "2025-08-04T00:00:00+01:00",
"documents": [
{
"documentType": "contractSigned",
"format": "application/pdf",
"id": "A-4406",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-4406"
},
{
"datePublished": "2025-08-20T08:17:02+01:00",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"format": "text/html",
"id": "049985-2025",
"noticeType": "UK7",
"url": "https://www.find-tender.service.gov.uk/Notice/049985-2025"
}
],
"hasRenewal": true,
"id": "1",
"period": {
"endDate": "2027-01-31T23:59:59Z",
"maxExtentDate": "2029-01-31T23:59:59Z",
"startDate": "2025-09-01T00:00:00+01:00"
},
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"status": "active",
"title": "NHS National Framework for Transition products (Nilotinib and Ticagrelor)",
"value": {
"amount": 22097000.0,
"amountGross": 26516400.0,
"currency": "GBP"
}
}
],
"date": "2025-08-20T08:17:02+01:00",
"id": "049985-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-04ff90",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 8UG",
"region": "UKI45",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"contactPoint": {
"email": "katie.noonan@nhs.net"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.england.nhs.uk/"
},
"id": "GB-PPON-PDPT-3135-BWWY",
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"name": "NHS England",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Bristol",
"postalCode": "BS1 6FL",
"region": "UKK11",
"streetAddress": "First Floor Templeback"
},
"contactPoint": {
"email": "josh.ferguson@zydusuk.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "sme",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-14646636",
"identifier": {
"id": "14646636",
"scheme": "GB-COH"
},
"name": "Zydus Pharmaceuticals UK Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Devon",
"postalCode": "EX32 8NS",
"region": "UKK43",
"streetAddress": "Whiddon Valley"
},
"contactPoint": {
"email": "hospmsg@accord-healthcare.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-00079585",
"identifier": {
"id": "00079585",
"scheme": "GB-COH"
},
"name": "Accord-UK Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "N1C 4AG",
"region": "UKI31",
"streetAddress": "2 Pancras Sq"
},
"contactPoint": {
"email": "roman.rojik@astrazeneca.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-03674842",
"identifier": {
"id": "03674842",
"scheme": "GB-COH"
},
"name": "AstraZeneca",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Cambridge",
"postalCode": "CB4 0PE",
"region": "UKH12",
"streetAddress": "410 Cambridge Science Park Milton Road"
},
"contactPoint": {
"email": "drlukhospital@drreddys.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "sme",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-01729064",
"identifier": {
"id": "01729064",
"scheme": "GB-COH"
},
"name": "Dr.Reddy\u0027s Laboratories (UK) Limited",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Hitchin",
"postalCode": "SG4 0TY",
"region": "UKH23",
"streetAddress": "Invision House"
},
"contactPoint": {
"email": "jocelyn.ligas@msnlabs.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-10185013",
"identifier": {
"id": "10185013",
"scheme": "GB-COH"
},
"name": "MSN Laboratories Europe Limited",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "W12 7FQ",
"region": "UKI33",
"streetAddress": "2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane,"
},
"contactPoint": {
"email": "commercial.pricing@novartis.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-00119006",
"identifier": {
"id": "00119006",
"scheme": "GB-COH"
},
"name": "Novartis Pharmaceuticals UK Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "EC4A 1JP",
"region": "UKI31",
"streetAddress": "12 New Fetter Lane"
},
"contactPoint": {
"email": "ukcustomerservices@zentiva.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-02158996",
"identifier": {
"id": "02158996",
"scheme": "GB-COH"
},
"name": "Zentiva Pharma UK Ltd",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"coveredBy": [
"GPA"
],
"description": "Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025\nOffer reference number: CM/TNS/24/5721\nPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.\nPotential periods of call-offs under the framework agreement:\nCM/TNS/24/5721/01 - Nilotinib and Ticagrelor\nLot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months)\nLot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months)\nPublished By: Medicines Procurement and Supply Chain \u2013 NHS Medicines Value \u0026 Access, NHS England\nPlease note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.\nAdditional Unsuccessful supplier not listed due to technical error:\nTorrent Pharma (UK) Ltd",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
}
],
"id": "C352808",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "complete",
"techniques": {
"frameworkAgreement": {
"description": "Please refer to the ITO Documents for the Operation Description",
"method": "withReopeningCompetition",
"type": "closed"
},
"hasFrameworkAgreement": true
},
"title": "NHS National Framework for Transition products (Nilotinib and Ticagrelor)"
}
}